Globus Medical price target raised to $63 from $60 at BTIG

BTIG analyst Ryan Zimmerman raised the firm’s price target on Globus Medical to $63 from $60 and keeps a Buy rating on the shares. The analyst cites the company’s “strong” revenue beat and improving margins.